68-6

72/104

) Poudel S, Hirano S, Kurashima Y, Stefanidis D, Akiyama H, Eguchi S, Fukui T, Hagiwara M, Hashimoto D, Hida K, Izaki T, Iwase H, Kwamoto S, Otomo Y, Nagai E, Saito M, Takami H, Takeda Y, Toi M, Yamaue H, Yoshida M, Yoshida S, Kodera Y: A snapshot of surgical resident training in Japan: result of a national-level needs assessment survey. Surg Today, 2020; 49: 870-6.) YS Yap, J Chiu, Y Ito, T Ishikawa, T Aruga, Seung Jin Kim, T Toyama, T Saeki, M Saito, L Gounaris, F Su, Y Ji, Y Han, M Gazdoiu, N Masuda: Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer. Cancer Sci, 2020; 111: 3313-3326.) Nogami N, Nakai K, Horimoto Y, Mizushima A, Saito M: Factors affecting decisions regarding terminal care locations of patients with metastatic breast cancer. Am J Hosp Palliat Med, 2020; 37: 853-858.) Poudel S, Hirano S, Kurashima Y, Stefanidis D, Akiyama H, Eguchi S, Fukui T, Hagiwara M, Hashimoto D, Hida K, Izaki T, Iwase H, Kawamoto S, Otomo Y, Nagai E, Saito M, Takami H, Takeda Y, Toi M, Yamaue H, Yoshida M, Yoshida S, Kodera Y: Are gradu-ating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan. Surg Today, 2020; 50: 995-1001.) Kawase K, Yamashita H, Iwase H, Akashi-Tanaka S, Iijima K, Ishida T, Takeishi Y, Tanaka F, Doihara H, Nakano S, Yamauchi H, Masuda S: Current conditions and issues of physicians and working conditions at institu-636Case Rep, 2020; 6: 39. 27) Kaji S, Terashima M: Preventive effect on delayed gastric emptying of preserving the infra-pyloric vein in laparoscopic pylorus- preserving gastrectomy for early gastric cancer. Surg Endosc, 2020; 34: 3853-3860. 28) Fujita S, Yoshimoto Y, Shimada H: What are the important prognostic factors in gastric cancer with positive duodenal margins? A multi-institutional analysis. Surg Today, 2020.Breast Oncology〈Original Articles〉 1 2 3 4 5tions accredited by the Japanese Breast Cancer Society. Breast Cancer, 2020; 27: 159-165.) Kubo M, Kumamaru H, Isozumi U, Miyashita M, Nagahashi M, Kadoya T, Kojima Y, Aogi K, Hayashi N, Tamura K, Asaga S, Niikura N, Ogo E, Iijima K, Tanakura K, Yoshida M, Miyata H, Yamamoto Y, Imoto S, Jinno H: Annual report of the Japanese Breast Cancer Society registry for 2016. Breast Cancer, 2020; 27: 511-518.) Ogiya R, Niikura N, Kumamaru H, Takeuchi Y, Okamura T, Kinoshita T, K Aogi, Anan K, Iijima K, Ishida T, Iwamoto T, Kawai M, Kojima Y, Sakatani T, Sagara Y, Hayashi N, Masuoka H, Yoshida M, Miyata H, Tsuda H, Imoto S, Jinno H: Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry- based study. Breast Cancer Res Treat, 2020; 184: 585-596.) Hayashi N, Kumamaru H, Isozumi U, Aogi K, Asaga S, Iijima K, Kadoya T, Kojima Y, Kubo M, Miyashita M, Miyata H, Nagahashi M, Niikura N, Ogo E, Tamura K, Tanakura K, YamamotoY, Yoshida M, Imoto S, Hiromitsu J: Annual report of the Japanese Breast Cancer Registry for 2017: Breast Cancer, 2020; 27: 803-809.) Horimoto Y, Tanabe M: Intrinsic subtype distribution should vary according to institu-tions. Breast, 2020; 54: 349. 6 7 8 9 10) Sai S, Kim EH, Vares G, Suzuki M, Yu D, Horimoto Y, Hayashi M: Combination of Carbon-ion Beam and Dual Tyrosine Kinase Inhibitor, Lapatinib, Effectively Destroys HER2 positive Breast Cancer Stem-like Cells: Am J Cancer Res, 2020; 10: 2371-86. 11) Ishizuka Y, Horimoto Y, Nakamura M, Arakawa A, Fujita T, Iijima K, Saito M: Predictive factors for non-sentinel nodal metastasis in patients with sentinel lymph node-positive breast cancer: Anticancer Res, 2020; 40: 4405-12. 12) Horimoto Y, Sasahara N, Sasaki R, Hlaing MT, Sakaguchi A, Saeki H, Arakawa A, Himuro T, Saito M: High FOXA1 protein expression might predict late recurrence in patients with estrogen positive and HER2-negative breast cancer: Breast Cancer Res Treat, 2020; 183: